{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:51:27Z","timestamp":1792511487364,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,21]]},"DOI":"10.7759\/cureus.15818","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T04:08:22Z","timestamp":1624334902000},"source":"Crossref","is-referenced-by-count":8,"title":["Malignant Catatonia Versus Neuroleptic Malignant Syndrome"],"prefix":"10.7759","author":[{"given":"Saral","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinu","family":"Hirachan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Gerolemou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S118438","article-title":"Neuroleptic malignant syndrome: an easily overlooked neurologic emergency","volume":"13","author":"Oruch R","year":"2017","unstructured":"Oruch R, Pryme IF, Engelsen BA, Lund A. Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatr Dis Treat. 2017, 13:161-75. 10.2147\/NDT.S118438","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370905400704","article-title":"Catatonia: a syndrome appears, disappears, and is rediscovered","volume":"54","author":"Fink M","year":"2009","unstructured":"Fink M. Catatonia: a syndrome appears, disappears, and is rediscovered. Can J Psychiatry. 2009, 54:437-45. 10.1177\/070674370905400704","journal-title":"Can J Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.146.3.324","article-title":"Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome","volume":"146","author":"Castillo E","year":"1989","unstructured":"Castillo E, Rubin RT, Holsboer-Trachsler E. Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. Am J Psychiatry. 1989, 146:324-8. 10.1176\/ajp.146.3.324","journal-title":"Am J Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1990.tb06439.x","article-title":"The neuroleptic malignant syndrome and its differentiation from lethal catatonia","volume":"81","author":"Fleischhacker WW","year":"1990","unstructured":"Fleischhacker WW, Unterweger B, Kane JM, Hinterhuber H. The neuroleptic malignant syndrome and its differentiation from lethal catatonia. Acta Psychiatr Scand. 1990, 81:3-5. 10.1111\/j.1600-0447.1990.tb06439.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref5","article-title":"An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome","volume":"49","author":"van Rensburg R","year":"2019","unstructured":"van Rensburg R, Decloedt EH. An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome. Psychopharmacol Bull. 2019, 49:84-91.","journal-title":"Psychopharmacol Bull"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000001830","article-title":"A mixed presentation of serotonin syndrome versus neuroleptic malignant syndrome in a 12-year-old boy","volume":"35","author":"Ott M","year":"2019","unstructured":"Ott M, Werneke U. A mixed presentation of serotonin syndrome versus neuroleptic malignant syndrome in a 12-year-old boy. Pediatr Emerg Care. 2019, 35:e98. 10.1097\/PEC.0000000000001830","journal-title":"Pediatr Emerg Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders (DSM-5). American Psychiatric Association, 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen SA","year":"2016","unstructured":"Rasmussen SA, Mazurek MF, Rosebush PI. Catatonia: our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry. 2016, 6:391-8. 10.5498\/wjp.v6.i4.391","journal-title":"World J Psychiatry"},{"key":"ref9","article-title":"Catatonia","author":"Burrow JP","year":"2021","unstructured":"Burrow JP, Spurling BC, Marwaha R. Catatonia. 2021."},{"key":"ref10","article-title":"Atypical neuroleptic malignant syndrome precipitated by clozapine and quetiapine overdose: a diagnostic challenge","volume":"15","author":"Teo DC","year":"2018","unstructured":"Teo DC, Wong HK, Tan SN. Atypical neuroleptic malignant syndrome precipitated by clozapine and quetiapine overdose: a diagnostic challenge. Innov Clin Neurosci. 2018, 15:20-2.","journal-title":"Innov Clin Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/15622970701287369","article-title":"Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine","volume":"10","author":"Paparrigopoulos T","year":"2009","unstructured":"Paparrigopoulos T, Tzavellas E, Ferentinos P, Mourikis I, Liappas J. Catatonia as a risk factor for the development of neuroleptic malignant syndrome: report of a case following treatment with clozapine. World J Biol Psychiatry. 2009, 10:70-3. 10.1080\/15622970701287369","journal-title":"World J Biol Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199608000-00007","article-title":"Catatonia after benzodiazepine withdrawal","volume":"16","author":"Rosebush PI","year":"1996","unstructured":"Rosebush PI, Mazurek MF. Catatonia after benzodiazepine withdrawal. J Clin Psychopharmacol. 1996, 16:315-9. 10.1097\/00004714-199608000-00007","journal-title":"J Clin Psychopharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852900013407","article-title":"Is Lorazepam a treatment for neuroleptic malignant syndrome?","volume":"5","author":"Francis A","year":"2000","unstructured":"Francis A, Chandragiri S, Rizvi S, Koch M, Petrides G. Is Lorazepam a treatment for neuroleptic malignant syndrome?. CNS Spectr. 2000, 5:54-7. 10.1017\/s1092852900013407","journal-title":"CNS Spectr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61034-malignant-catatonia-versus-neuroleptic-malignant-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:18Z","timestamp":1707506718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61034-malignant-catatonia-versus-neuroleptic-malignant-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,21]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.15818","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,21]]}}}